What are ME/CFS & Long Covid?
Myalgic encephalomyelitis (ME), formerly known as chronic fatigue syndrome (CFS), is a chronic, complex, neuroimmune disease that profoundly limits the health and productivity of patients and is often triggered by an infection. Long Covid describes a collection of lingering symptoms following COVID-19.
They are thought to be related as they both can follow infection and exhibit many of the same prevalent symptoms: crippling fatigue, post-exertional malaise and cognitive dysfunction. There is no cure for either, nor are there any FDA-approved drugs or treatment so there is a dire need for more research into these disorders.
Core Programs
Solve M.E. takes a holistic approach to research and advocacy, catalyzing efforts through our various programs to make ME/CFS, Long Covid, and other “long haul” diseases better understood, diagnosable, and treatable. We are the largest U.S. peer-reviewed provider of private competitive research funding exclusively for ME/CFS, and the partner of choice for strategic, collaborative relationships with patients, researchers, government officials, and other disease organizations across the globe.
Groundbreaking Research
Our Research
Harnessing the Power of Big Data
You + ME Registry
Inspiring Advocacy
Make an Impact
Forging Alliances
Join the LCAJoin Us for Advocacy Week April 17-22!
Connect with your elected officials and share your story with your members of Congress to inspire policy solutions for ME/CFS, Long Covid, and other post-infection diseases.
Solve Launches First National Long Covid PSA
“How Long?” was designed to broaden awareness of Long Covid, ME/CFS, and other post-infection diseases; create empathy for those who suffer their devastating impact; and highlight the need for research to better understand them in order to adequately help patients.
Long Covid's Prevalence and Economic Impact
Our Solve Long Covid Initiative launched a new whitepaper, Long Covid’s Impact on Adult Americans: Early Indicators Estimating Prevalence and Cost, estimating the magnitude of the Long Covid public health crisis.
Long Covid: What Will It Take to Accelerate Therapeutic Progress?
Solve recently co-hosted a virtual event convening stakeholders to advance research and development to diagnose and treat Long Covid, ME/CFS, and other post-infection diseases. We engaged drug developers and informed them of the unmet needs of our communities to inspire them to study these diseases and create therapeutic breakthroughs.
Long Haul Voices: Living with Long Covid and ME/CFS
Long Haul Voices is a mini-series created in partnership with Unfixed Media Productions that amplifies the experiences of individuals with Long Covid and ME/CFS, the experts devoted to improving their care, and the challenges surrounding these largely invisible, poorly-understood diseases that affect a rapidly growing population.
About Us
The Solve ME/CFS Initiative (Solve M.E.) is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases. Our work with the scientific, medical, and pharmaceutical communities, advocacy with government agencies, and alliances with patient groups around the world is laying the foundation for breakthroughs that can improve the lives of millions who suffer from various “long haul” diseases.
